Mayinglong Pharmaceutical Group (600993) Stock Overview

Mayinglong Pharmaceutical Group Co., LTD. engages in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. The company products pipeline primarily consists of functional cosmetics, functional care products, functional food, and Chinese herbal medicines, as well as hemorrhoid, gynecological, cough, and skin products; and medical instruments. It is also involved in the retail and wholesale of medical devices and drugs; provision of hospital medical services; and operation of hospitals. The company sells its products through online channels. Mayinglong Pharmaceutical Group Co., LTD. was founded in 1582 and is headquartered in Wuhan, China.